The CSF orexin levels of NPC patients were significantly higher than those of patients with narcolepsy-cataplexy (NT1)(p < 0.01) and lower than those of patients with IHS (p < 0.01), which was considered as the control group with normal CSF orexin levels. The gene discussed is HCRT; the disease is nasopharyngeal carcinoma.